Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2026-02-26 @ 4:19 PM
Study NCT ID:
NCT01575860
Status:
COMPLETED
Last Update Posted:
2023-03-27
First Post:
2012-04-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Maintenance Lenalidomide in Lymphoma
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2018-05-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-10
First Submit QC Date:
None
Study First Post Date:
2012-04-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-04-28
Results First Submit QC Date:
None
Results First Post Date:
2020-09-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-23
Last Update Post Date:
2023-03-27
Last Update Post Date Type:
ACTUAL